10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ABBOTT LABORATORIES | |||
Ticker: ABT Fiscal Year: 2013 | |||
Consolidated Statement of Earnings | |||
Period Ending Dec 31, 2013 10-K (Filed: Feb 21, 2014) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
| Net Sales | $ 21,848 | 21,494 | 21,407 |
| Cost of products sold | 10,040 | 9,817 | 10,017 |
| Amortization of intangible assets | 791 | 795 | 884 |
| Research and development | 1,452 | 1,544 | 1,512 |
| Selling, general and administrative | 6,936 | 7,444 | 7,365 |
| Total Operating Cost and Expenses | 19,219 | 19,600 | 19,778 |
| Operating Earnings | 2,629 | 1,894 | 1,629 |
| Interest expense | 157 | 347 | 359 |
| Interest income | (67) | (59) | (65) |
| Net loss on extinguishment of debt | 1,351 | ||
| Net foreign exchange (gain) loss | 50 | (25) | (20) |
| Other (income) expense, net | (32) | (25) | 119 |
| Earnings from Continuing Operations Before Taxes | 2,521 | 305 | 1,236 |
| Taxes on Earnings from Continuing Operations | 138 | (274) | 110 |
| Earnings from Continuing Operations | 2,383 | 579 | 1,126 |
| Less: Earnings from Discontinued Operations, net of tax | 193 | 5,384 | 3,602 |
| Net Earnings | 2,576 | 5,963 | 4,728 |
| Basic Earnings Per Common Share | |||
| Continuing Operations (in dollars per share) | 1.52 | 0.36 | 0.72 |
| Discontinued Operations (in dollars per share) | 0.12 | 3.40 | 2.31 |
| Net Earnings (in dollars per share) | 1.64 | 3.76 | 3.03 |
| Diluted Earnings Per Common Share | |||
| Continuing Operations (in dollars per share) | 1.50 | 0.36 | 0.72 |
| Discontinued Operations (in dollars per share) | 0.12 | 3.36 | 2.29 |
| Net Earnings (in dollars per share) | 1.62 | 3.72 | 3.01 |
| Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares) | 1,558 | 1,575 | 1,557 |
| Dilutive Common Stock Options and Awards (in shares) | 16 | 17 | 10 |
| Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options and Awards (in shares) | 1,574 | 1,592 | 1,567 |
| Outstanding Common Stock Options Having No Dilutive Effect (in shares) | 1 | 1 | 27 |
| External Links | |
| ABBOTT LABORATORIES (ABT) Fiscal Year 2013 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |